CLOV übertreffen die 14 der letzten 19Schätzungen.
74%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate forQ4 25(Revenue/ EPS)
$476.40M
/
-$0.10
Implizierte Änderung vonQ3 25(Revenue/ EPS)
-4.08%
/
+100.00%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+41.38%
/
+150.00%
Clover Health Investments, Corp earnings per share and revenue
On 04. Nov. 2025, CLOV reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.03 USD, resulting in a -63.40% surprise. Revenue reached 496.65 million, compared to an expected 480.51 million, with a 3.36% difference. The market reacted with a -15.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 476.40 million USD, implying an increase of 100.00% EPS, and decrease of -4.08% in Revenue from the last quarter.
FAQ
What were Clover Health Investments, Corp's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Clover Health Investments, Corp reported EPS of -$0.05, missing estimates by -63.4%, and revenue of $496.65M, 3.36% above expectations.
How did the market react to Clover Health Investments, Corp's Q3 2025 earnings?
The stock price moved down -15.77%, changed from $3.52 before the earnings release to $2.96 the day after.
When is Clover Health Investments, Corp expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Clover Health Investments, Corp's next earnings report?
Based on 5
analysts, Clover Health Investments, Corp is expected to report EPS of -$0.10 and revenue of $476.40M for Q4 2025.